![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
| Anticuerpo monoclonal ligado a una sustancia tóxica. Está en estudio para el tratamiento del melanoma que se ha diseminado hasta partes distantes del cuerpo. La IgG-RFT5-dgA se produce en el laboratorio. Puede encontrar y destruir ciertos glóbulos blancos que impiden que el sistema inmunitario destruya las células cancerosas. También se llama inmunotoxina RFT5-dgA. |
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20081011234650im_/http://www.nci.nih.gov/images/spacer.gif) |